{"license":"https://creativecommons.org/licenses/by/4.0/","dataset":"sources","count":1,"filters":{"source":"ftc-pbm-insulin-complaint-2024","sourceMatched":true,"sourceId":"ftc-pbm-insulin-complaint-2024","sourceTitle":"FTC Sues Prescription Drug Middlemen for Artificially Inflating Insulin Drug Prices","sourcePublisher":"Federal Trade Commission","sourceProfileHref":"/sources/ftc-pbm-insulin-complaint-2024"},"rows":[{"id":"ftc-pbm-insulin-complaint-2024","title":"FTC Sues Prescription Drug Middlemen for Artificially Inflating Insulin Drug Prices","publisher":"Federal Trade Commission","citationAuthor":"Federal Trade Commission","citationAuthorType":"organization","citationYear":2024,"url":"https://www.ftc.gov/news-events/news/press-releases/2024/09/ftc-sues-prescription-drug-middlemen-artificially-inflating-insulin-drug-prices","description":"FTC administrative complaint record concerning alleged rebating and formulary practices by the three largest PBMs and affiliated GPOs.","sourceType":"agency_report","accessDate":"2026-07-17","citationText":"Federal Trade Commission, FTC Sues Prescription Drug Middlemen for Artificially Inflating Insulin Drug Prices, September 20 2024.","licenseNote":"Public federal government record","archivedUrl":null,"markets":[{"id":"mkt-pbm","slug":"us-pharmacy-benefit-management","name":"U.S. pharmacy benefit management","shortName":"PBMs","description":"Pharmacy benefit management services profile based on FTC public findings. The FTC reports top-three and top-six aggregate shares but not enough individual PBM market shares in the public press-release record to compute HHI.","geography":"United States","sector":"Health care","naicsCode":"524292","sicCode":null,"sourceNotes":"FTC interim staff report says top three PBMs processed nearly 80 percent of prescriptions and top six processed more than 90 percent in 2023.","methodologyNotes":"Show aggregate public facts and withhold HHI until individual firm-level shares are public and citable.","dataVintage":"2023","isFeatured":false}],"canonicalCitation":"Federal Trade Commission, FTC Sues Prescription Drug Middlemen for Artificially Inflating Insulin Drug Prices, September 20 2024. Available at https://www.ftc.gov/news-events/news/press-releases/2024/09/ftc-sues-prescription-drug-middlemen-artificially-inflating-insulin-drug-prices. Accessed Jul 17, 2026. Antitrust Radar source record ftc-pbm-insulin-complaint-2024: https://antitrustradar.org/sources/ftc-pbm-insulin-complaint-2024","citationDownloads":{"bibtex":"/sources/ftc-pbm-insulin-complaint-2024/citation/bibtex","ris":"/sources/ftc-pbm-insulin-complaint-2024/citation/ris"},"profileHref":"/sources/ftc-pbm-insulin-complaint-2024"}]}